U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06972446) titled 'A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis' on May 07.
Brief Summary: Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheumatoid Arthritis (RA).
This study currently includes 3 substudies evaluating different treatments in participants with RA. Substudy 1 will evaluate lutikizumab compared to placebo (looks like the study treatment but contains no medicine). Substud...